Aligos Therapeutics, Inc. — Investor Relations & Filings
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for liver and viral diseases. The company leverages expertise in medicinal chemistry and biology to create differentiated, best-in-class drug candidates for conditions with significant unmet medical needs. Its development pipeline features Pevifoscorvir sodium, an oral small molecule capsid assembly modulator (CAM-E) for chronic hepatitis B (CHB), and ALG-055009, an oral small molecule thyroid hormone receptor beta (THR-β) agonist for metabolic dysfunction-associated steatohepatitis (MASH). Aligos aims to develop therapies with enhanced pharmacologic properties suitable for both monotherapy and combination treatment regimens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Aligos Therapeutics, Inc. (0001799448) (Filer) | 2026-04-21 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-02-04 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| 10-Q | 2025-11-06 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 34922357 | 8-K - Aligos Therapeutics, Inc. (0001799448) (Filer) | 2026-04-21 | English | ||
| 31762692 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31762717 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 31762711 | 8-K Filing | 2026-02-04 | English | ||
|
2025
11 filings
| |||||
| 13227302 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13227303 | 10-Q | 2025-11-06 | English | ||
| 13227304 | FORM 8-K | 2025-11-06 | English | ||
| 13227305 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 13227306 | Major Shareholding Notification 2025 | 2025-08-13 | English | ||
| 13227307 | Major Shareholding Notification 2025 | 2025-08-12 | English | ||
| 13227308 | S-8 | 2025-08-06 | English | ||
| 13227309 | 10-Q | 2025-08-06 | English | ||
| 13227310 | FORM 8-K | 2025-08-06 | English | ||
| 13227311 | Director's Dealing 2025 | 2025-07-18 | English | ||
| 13227312 | Director's Dealing 2025 | 2025-07-18 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
Aligos Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34431/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34431 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34431 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34431 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34431}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aligos Therapeutics, Inc. (id: 34431)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.